Permanence Bio Anti-Cancer Drugs
3 known investors
Permanence Bio is a biotech company developing therapies aimed at cancer prevention by protecting the genome from damage, drawing on aging and DNA repair research. It works to discover cancer-preventing compounds and advance lead compounds from mechanism of action through IND-enabling studies and into the clinic.
Founders & leadership
AT
Alan TomusiakCEO
Investors · 3
.jpeg){kind=logo}
Frequently asked questions
- What does Permanence Bio Anti-Cancer Drugs do?
- Permanence Bio is a biotech company developing therapies aimed at cancer prevention by protecting the genome from damage, drawing on aging and DNA repair research. It works to discover cancer-preventing compounds and advance lead compounds from mechanism of action through IND-enabling studies and into the clinic.
- Who are Permanence Bio Anti-Cancer Drugs's investors?
- Permanence Bio Anti-Cancer Drugs's investors include Impatient Ventures, NFX, Spacecadet Ventures.